Swiss Drugmaker Extrovis Sues Ex-Partner For IP Portfolio
Extrovis AG is suing its former joint venture partner to reclaim ownership of a patent portfolio covering medications which counter the effects of opioids and other products, alleging that its former...To view the full article, register now.
Already a subscriber? Click here to view full article